Aethlon Medical (AEMD US)

Analysis

Health Care • United States

Aethlon Medical, Inc. operates as a medical device company. The Company provides a platform to develop medical devices that target the selective removal of disease-promoting particles from the circulatory system. Aethlon Medical develops medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions.

Refresh

Company Presentation • 09 May 2024 19:00

Corporate presentation

Company Presentation • 27 Jan 2023 20:00

Sequire Biotechnology Conference presentation

Company Presentation • 26 Aug 2022 19:00

H.C. Wainwright 24th Annual Global Investment Conference presentation

Company Presentation • 13 Sep 2021 19:00

H.C. Wainwright 23rd Annual Global Investment Conference presentation

Company Presentation • 04 Mar 2021 20:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Corporate presentation

Sequire Biotechnology Conference presentation

H.C. Wainwright 24th Annual Global Investment Conference presentation

H.C. Wainwright 23rd Annual Global Investment Conference presentation

Investor presentation